- With US on board, COVID IP waiver still faces long road
- Opening up negotiations
- Speedier vaccines?
- Trade secrets as flashpoint
Law360: While the Biden administration has backed a temporary waiver on intellectual property protections for coronavirus (COVID-19) vaccines, experts now foresee heated World Trade Organization (WTO) negotiations about the scope of any deal, which could keep the proposal in limbo for some time.
Sign in or take a trial to read the full analysis.
To continue reading this news article, as well as thousands of others like it, sign in to LexisPSL or register for a free trial